CJC-1295 with DAC (5mg)
CJC-1295 with DAC — GHRH Analog Research
Order CJC-1295 with DAC (5mg) online for laboratory research. Compare the listed vial options and current price, then add your selection to cart and continue to checkout. Review available COA records for the exact product, strength and lot. Research Use Only; not for human or veterinary use.
CJC-1295 w/DAC is listed for growth hormone laboratory research. Catalog vial contents are 5mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
Research Applications & Benefits
- Albumin-binding analog research
- Growth hormone and IGF-I measurements
- DAC-specific identity verification
What is CJC-1295 w/DAC?
CJC-1295 with DAC is a modified growth-hormone-releasing hormone (GHRH) analog. DAC means Drug Affinity Complex. This catalog lists a 5mg vial for in-vitro laboratory research, not a finished medicine.
Listed vial contents: 5mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.
Which identity should I verify?
CJC-1295 with DAC and Mod GRF 1-29, often called CJC-1295 No DAC, are distinct constructs. Verify the sequence, DAC modification and molecular identity against an original matching lot document. A catalog name or CAS number alone is not confirmation.
What mechanisms are being studied?
GHRH signals the pituitary to release growth hormone. The DAC modification allows the studied molecule to bind albumin, a blood protein. Researchers examine how this changes the duration of growth hormone and insulin-like growth factor I (IGF-I) responses.
What are the research questions?
- Albumin binding and persistence of a defined GHRH analog
- Growth hormone and IGF-I responses in controlled experimental settings
- Whether hormone pulses persist during prolonged GHRH stimulation
What does the published work describe?
Jetté and colleagues' 2005 paper characterized CJC-1295 as a long-lasting GRF analog. Teichman and colleagues' 2006 trials in healthy adults measured prolonged growth hormone and IGF-I responses. Ionescu and Frohman's 2006 study examined continued pulsatile growth hormone secretion. These papers describe the tested DAC-containing material, not a clinical trial of this catalog vial.
Experimental models in the cited papers
- Experimental characterization of a long-lasting GRF analog
- Healthy adults: growth hormone and IGF-I measurements
- Human growth hormone pulsatility study
What could future research explore?
Future research could investigate how albumin binding changes receptor signaling and hormone feedback. Possible therapeutic applications would require condition-specific trials with a defined formulation. Changes in hormone measurements alone do not establish improvements in recovery, sleep or body composition.
These are research directions, not established applications of the product sold here.
What are the limits of this evidence?
The cited studies do not establish this research vial's identity, purity, effectiveness or safety. Findings for CJC-1295 with DAC cannot be transferred to Mod GRF 1-29 without DAC or to a peptide blend. Short studies in healthy adults do not establish long-term safety or treatment benefit.
Study references
- Jetté L, et al. Identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 2005. PMID 15817669
- Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006. PMID 16352683
- Ionescu M, Frohman LA. Pulsatile secretion of growth hormone persists during continuous stimulation by CJC-1295. J Clin Endocrinol Metab. 2006. PMID 17018654
How should I check lot documentation?
Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. A report is evidence only for the product, strength and lot it names.
How is CJC-1295 w/DAC handled in the lab?
For CJC-1295 w/DAC, record the product code CJC-DAC, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
Choose a solvent for CJC-1295 w/DAC from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay.
For CJC-1295 w/DAC, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; no usable molecular weight is established by the blank catalog field. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
Use the documented storage conditions for the supplied CJC-1295 w/DAC form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
A CJC-1295 w/DAC laboratory protocol should record identity, product code CJC-DAC, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Research Use Only. Not for human consumption, therapeutic, veterinary or any in-vivo use.
Product Specifications
- Compound
- CJC-1295 w/DAC
- CAS Number
- Molecular Weight
- HPLC Purity Specification
- ≥99%
- Category
- Growth Hormone
- Starting Price
- $49.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
CJC-1295 w/DAC has a catalog purity specification of ≥99%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
Frequently Asked Questions
What is CJC-1295 w/DAC?
CJC-1295 w/DAC is listed for growth hormone laboratory research. Catalog vial contents are 5mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
What strengths of CJC-1295 w/DAC are available?
The catalog lists 5mg. These labels describe vial contents, not administration doses. Select the required strength for current pricing and availability; match analysis records to that exact strength and lot.
How should I interpret CJC-1295 w/DAC purity results?
CJC-1295 w/DAC has a catalog purity specification of ≥99%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
How should CJC-1295 w/DAC be handled in the laboratory?
For CJC-1295 w/DAC, record the product code CJC-DAC, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
How do I choose a laboratory solvent for CJC-1295 w/DAC?
Choose a solvent for CJC-1295 w/DAC from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay.
How do I calculate a CJC-1295 w/DAC stock concentration?
For CJC-1295 w/DAC, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; no usable molecular weight is established by the blank catalog field. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
How should CJC-1295 w/DAC be stored after preparation?
Use the documented storage conditions for the supplied CJC-1295 w/DAC form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
What should a CJC-1295 w/DAC lab protocol document?
A CJC-1295 w/DAC laboratory protocol should record identity, product code CJC-DAC, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Does Fmoc or Boc synthesis explain this CJC-1295 w/DAC product?
Fmoc and Boc are peptide protecting-group strategies, not proof of how this CJC-1295 w/DAC lot was made. For sequence-defined peptides, synthesis review can examine deletion products, incomplete deprotection and modifications using the method and matching analytical evidence. A single chromatographic peak does not by itself establish sequence.
Is CJC-1295 w/DAC for human use?
No. CJC-1295 w/DAC is strictly Research Use Only. It is not intended for human or veterinary use, diagnosis or treatment. Laboratory handling guidance is not an administration protocol.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
